These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 1156056)

  • 1. Response of uremic patients to nandrolone decanoate.
    Doane BD; Fried W; Schwartz F
    Arch Intern Med; 1975 Jul; 135(7):972-5. PubMed ID: 1156056
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nandrolone decanoate therapy for patients receiving hemodialysis. A controlled study.
    Williams JS; Stein JH; Ferris TF
    Arch Intern Med; 1974 Aug; 134(2):289-92. PubMed ID: 4602048
    [No Abstract]   [Full Text] [Related]  

  • 3. Plasma erythropoietin levels in patients undergoing long-term hemodialysis.
    Raich PC; Korst DR
    Arch Pathol Lab Med; 1978 Feb; 102(2):73-5. PubMed ID: 579968
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A controlled trial of recombinant human erythropoietin and nandrolone decanoate in the treatment of anemia in patients on chronic hemodialysis.
    Berns JS; Rudnick MR; Cohen RM
    Clin Nephrol; 1992 May; 37(5):264-7. PubMed ID: 1606777
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nutritional effect of nandrolone decanoate in predialysis patients with chronic kidney disease.
    Eiam-Ong S; Buranaosot S; Eiam-Ong S; Wathanavaha A; Pansin P
    J Ren Nutr; 2007 May; 17(3):173-8. PubMed ID: 17462549
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relative contributions of body iron status and uremia severity to anemia in patients with advanced chronic renal failure.
    Ifudu O; Dawood M; Friedman EA
    Nephron; 1997; 77(3):315-8. PubMed ID: 9375826
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effects of nandrolone decanoate on nutritional parameters in hemodialysis patients.
    Barton Pai A; Chretien C; Lau AH
    Clin Nephrol; 2002 Jul; 58(1):38-46. PubMed ID: 12141405
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potential role of parathyroid hormone as an inhibitor of erythropoiesis in the anemia of renal failure.
    McGonigle RJ; Wallin JD; Husserl F; Deftos LJ; Rice JC; O'Neill WJ; Fisher JW
    J Lab Clin Med; 1984 Dec; 104(6):1016-26. PubMed ID: 6501997
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of chronic uremia in childhood. II. Hemodialysis.
    Potter D; Larsen D; Leumann E; Perin D; Simmons J; Piel CF; Holliday MA
    Pediatrics; 1970 Nov; 46(5):678-89. PubMed ID: 4921218
    [No Abstract]   [Full Text] [Related]  

  • 10. The role of nandrolone decanoate in patients with end stage renal disease in the erythropoietin era.
    Johansen KL
    Int J Artif Organs; 2001 Apr; 24(4):183-5. PubMed ID: 11394696
    [No Abstract]   [Full Text] [Related]  

  • 11. [The effect of hemodialysis and continuous ambulatory peritoneal dialysis on renal anemia].
    Stojimirović B; Grujić-Adanja G
    Srp Arh Celok Lek; 1997; 125(5-6):163-7. PubMed ID: 9265238
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anemia of uremia responsive to increased dialysis treatment.
    Lindholm DD; Pace RL; Russell HH
    Trans Am Soc Artif Intern Organs; 1969; 15():360-6. PubMed ID: 5791410
    [No Abstract]   [Full Text] [Related]  

  • 14. A controlled trial of nondrolone decanoate in the treatment of uremic anemia.
    Cattran DC; Fenton SS; Wilson DR; Oreopoulos D; Shimizu A; Richardson RM
    Kidney Int; 1977 Dec; 12(6):430-7. PubMed ID: 609193
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intravenous iron sucrose in Chinese hemodialysis patients with renal anemia.
    Li H; Wang SX
    Blood Purif; 2008; 26(2):151-6. PubMed ID: 18212498
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Controlled study of androgen therapy in anemia of patients on maintenance hemodialysis.
    Hendler ED; Goffinet JA; Ross S; Longnecker RE; Bakovic V
    N Engl J Med; 1974 Nov; 291(20):1046-51. PubMed ID: 4606387
    [No Abstract]   [Full Text] [Related]  

  • 17. Gastro-duodenal lesions and Helicobacter pylori infection in uremic patients and renal transplant recipients.
    Khedmat H; Ahmadzad-Asl M; Amini M; Lessan-Pezeshki M; Einollahi B; Pourfarziani V; Naseri MH; Davoudi F
    Transplant Proc; 2007 May; 39(4):1003-7. PubMed ID: 17524875
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Anemia in chronic renal insufficiency].
    Heilmann E
    Fortschr Med; 1975 Dec; 93(34):1718-20. PubMed ID: 1193526
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Anemia in patients with chronic kidney failure undergoing systematic hemodialysis treatment].
    Landar' VA; Sarycheva TG; Shemetov VD; Kozinets GI
    Urol Nefrol (Mosk); 1989; (1):54-5. PubMed ID: 2718284
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [19-norandrostenolone undecylate in the treatment of anemia in patients treated with periodic hemodialysis].
    Docci D; Feliciangeli G; Mosconi G; Vangelista A; Stefoni S
    G Clin Med; 1981 Aug; 62(8):567-75. PubMed ID: 7308639
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.